triazoles has been researched along with cefazolin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Actor, P; Berges, DA; Dunn, GL; Guarini, JR; Hoover, JR; Phillips, L; Sachs, CS; Uri, JV; Weisbach, JA; Zajac, I | 1 |
Actor, P; Bran, JL; Lucyszyn, G; Pitkin, DH; Weisbach, JA | 1 |
Kleinpeter, MA | 1 |
Harada, AS; Lau, W | 1 |
1 review(s) available for triazoles and cefazolin
Article | Year |
---|---|
Successful treatment of Candida infections in peritoneal dialysis patients: case reports and review of the literature.
Topics: Aged; Antifungal Agents; Candidiasis; Catheters, Indwelling; Cefazolin; Female; Humans; Middle Aged; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2004 |
3 other study(ies) available for triazoles and cefazolin
Article | Year |
---|---|
Laboratory studies with cefatrizine (SK + F 60771), a new broad-spectrum orally-active cephalosporin.
Topics: Administration, Oral; Animals; Cefazolin; Cephalexin; Cephalosporins; Dogs; Drug Evaluation, Preclinical; Escherichia coli; Haplorhini; Klebsiella pneumoniae; Male; Mice; Microbial Sensitivity Tests; Rabbits; Staphylococcus aureus; Triazoles | 1975 |
Cefatrizine (SK&F 60771), a new oral cephalosporin: serum levels and urinary recovery in humans after oral or intramuscular administration--comparative study with cephalexin and cefazolin.
Topics: Administration, Oral; Cefazolin; Cephalexin; Cephalosporins; Humans; Injections, Intramuscular; Male; Time Factors; Triazoles | 1976 |
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole | 2007 |